Archive for 'Cell therapy'

Biomanufacturing: Walloon player Novasep offers now all the CDMO services!

Biomanufacturing: Walloon player Novasep offers now all the CDMO services!

In 2016 and beyond, biomanufacturing will be high among the BioWin pole priorities. A sector in which Wallonia has no shortage of qualified players and resources to ensure it is well placed to meet future challenges. [...]

MaSTherCell or the future of CMOs

MaSTherCell or the future of CMOs

In an exclusive interview, Hugues Bultot, Chief Executive Officer of MaSTherCell, an emerging pioneer in the industrialization of cell-based therapeutics, based in Gosselies (Belgium) shares with us his vision for the future of the CMO.   [...]

Pluriomics raises €4M and settles its production facility in Wallonia!

Pluriomics raises €4M and settles its production facility in Wallonia!

Pluriomics, an emerging biotech company located in Leiden (The Netherlands) and specializing in the delivery of innovative cardiomyocyte models, has raised €4 million in a Series A round to strengthen its R&D and commercial team in [...]

Bone Therapeutics raises EUR 32.2 million through IPO

Bone Therapeutics raises EUR 32.2 million through IPO

Bone Therapeutics – a Walloon cell therapy company specialized in bone fracture repair and prevention – shifts up a gear and raises EUR 32.2 million in a 2.5x oversubscribed successful IPO on Brussels and Paris Euronext [...]

ImCyse plans first-in-human-therapy(FIHT) with disease-modifying vaccine to treat multiple sclerosis

ImCyse plans first-in-human-therapy(FIHT) with disease-modifying vaccine to treat multiple sclerosis

Belgian-based ImCyse, a spin-off originally from the Catholic University of Leuven (KUL), but now established at both KUL and University of Liège (ULg), was founded in July 2010 by Prof. Jean-Marie Saint-Remy to valorize discoveries made [...]

Opening Bell Ceremony kicks off Advanced Therapies Investor Day (Brussels)

Opening Bell Ceremony kicks off Advanced Therapies Investor Day (Brussels)

The first European Advanced Therapies Investor Day began with the sound of  the “opening bell” of the Euronext stock market (Brussels) resonating the potential of the rapidly expanding sector of advanced therapies. Watch ceremony For the [...]

Marie Curie research grant awards €3.8 million in funding to Bone Therapeutics (Gosselies, Belgium) and partners

Marie Curie research grant awards €3.8 million in funding to Bone Therapeutics (Gosselies, Belgium) and partners

As part of an expert pan-European consortium* BONE THERAPEUTICS has been awarded a share of the highly competitive Marie Curie grant1 in the amount of €3.8 million. The grant will fund a four-year project entitled BIO-INSPIRE [...]

Cardio3 BioSciences raises € 4.0 million from the Walloon Region (non-dilutive funding)

Cardio3 BioSciences raises € 4.0 million from the Walloon Region (non-dilutive funding)

Cardio3 BioSciences SA has announced that it has received €4.0 million of non-dilutive funding from the Walloon Region through the conclusion of a new recoverable cash advance (RCA) granted for an amount of €2.5 million and [...]

Belgium’s Promethera Biosciences and St. Luc University (UCL) receive praise in Japan

Belgium’s Promethera Biosciences and St. Luc University (UCL) receive praise in Japan

An article in the Japanese press is praising the quality of research in cellular therapy at the UCL within the laboratory of Prof. Etienne Sokal and at Louvain-born spin-off Promethera Biosciences. The article on regenerative medicine, [...]

Quality Assistance (Thuin, Belgium) faces challenge of attracting qualified personnel

Quality Assistance (Thuin, Belgium) faces challenge of attracting qualified personnel

Now hiring! Quality Assistance (QA), a contract research organization (CRO) dedicated to 3rd generation medicines, has announced a €4.5 million investment over the next 18 months and a commitment to creating 15 new jobs by the [...]